Cargando…

Effects of liposomal-curcumin on five opportunistic bacterial strains found in the equine hindgut - preliminary study

BACKGROUND: The horse intestinal tract is sensitive and contains a highly complex microbial population. A shift in the microbial population can lead to various issues such as inflammation and colic. The use of nutraceuticals in the equine industry is on the rise and curcumin is thought to possess an...

Descripción completa

Detalles Bibliográficos
Autores principales: Bland, S. D., Venable, E. B., McPherson, J. L., Atkinson, R. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473976/
https://www.ncbi.nlm.nih.gov/pubmed/28638626
http://dx.doi.org/10.1186/s40781-017-0138-4
_version_ 1783244385930969088
author Bland, S. D.
Venable, E. B.
McPherson, J. L.
Atkinson, R. L.
author_facet Bland, S. D.
Venable, E. B.
McPherson, J. L.
Atkinson, R. L.
author_sort Bland, S. D.
collection PubMed
description BACKGROUND: The horse intestinal tract is sensitive and contains a highly complex microbial population. A shift in the microbial population can lead to various issues such as inflammation and colic. The use of nutraceuticals in the equine industry is on the rise and curcumin is thought to possess antimicrobial properties that may help to minimize the proliferation of opportunistic bacteria. METHODS: Four cecally-cannulated horses were utilized to determine the optimal dose of liposomal-curcumin (LIPC) on reducing Streptococcus bovis/equinus complex (SBEC), Escherichia coli K-12, Escherichia coli general, Clostridium difficile, and Clostridium perfringens in the equine hindgut without adversely affecting cecal characteristics. In the first study cecal fluid was collected from each horse and composited for an in vitro, 24 h batch culture to examine LIPC at four different dosages (15, 20, 25, and 30 g) in a completely randomized design. A subsequent in vivo 4 × 4 Latin square design study was conducted to evaluate no LIPC (control, CON) or LIPC dosed at 15, 25, and 35 g per day (dosages determined from in vitro results) for 9 days on the efficacy of LIPC on selected bacterial strains, pH, and volatile fatty acids. Each period was 14 days with 9 d for acclimation and 5 d withdrawal period. RESULTS: In the in vitro study dosage had no effect (P ≥ 0.42) on Clostridium strains, but as the dose increased SBEC concentrations increased (P = 0.001). Concentrations of the E. coli strain varied with dose. In vivo, LIPC’s antimicrobial properties, at 15 g, significantly decreased (P = 0.02) SBEC when compared to 25 and 35 g dosages. C. perfringens decreased linearly (P = 0.03) as LIPC dose increased. Butyrate decreased linearly (P = 0.01) as LIPC dose increased. CONCLUSION: Further studies should be conducted with a longer dosing period to examine the antimicrobial properties of curcumin without adversely affecting cecal characteristics.
format Online
Article
Text
id pubmed-5473976
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54739762017-06-21 Effects of liposomal-curcumin on five opportunistic bacterial strains found in the equine hindgut - preliminary study Bland, S. D. Venable, E. B. McPherson, J. L. Atkinson, R. L. J Anim Sci Technol Research BACKGROUND: The horse intestinal tract is sensitive and contains a highly complex microbial population. A shift in the microbial population can lead to various issues such as inflammation and colic. The use of nutraceuticals in the equine industry is on the rise and curcumin is thought to possess antimicrobial properties that may help to minimize the proliferation of opportunistic bacteria. METHODS: Four cecally-cannulated horses were utilized to determine the optimal dose of liposomal-curcumin (LIPC) on reducing Streptococcus bovis/equinus complex (SBEC), Escherichia coli K-12, Escherichia coli general, Clostridium difficile, and Clostridium perfringens in the equine hindgut without adversely affecting cecal characteristics. In the first study cecal fluid was collected from each horse and composited for an in vitro, 24 h batch culture to examine LIPC at four different dosages (15, 20, 25, and 30 g) in a completely randomized design. A subsequent in vivo 4 × 4 Latin square design study was conducted to evaluate no LIPC (control, CON) or LIPC dosed at 15, 25, and 35 g per day (dosages determined from in vitro results) for 9 days on the efficacy of LIPC on selected bacterial strains, pH, and volatile fatty acids. Each period was 14 days with 9 d for acclimation and 5 d withdrawal period. RESULTS: In the in vitro study dosage had no effect (P ≥ 0.42) on Clostridium strains, but as the dose increased SBEC concentrations increased (P = 0.001). Concentrations of the E. coli strain varied with dose. In vivo, LIPC’s antimicrobial properties, at 15 g, significantly decreased (P = 0.02) SBEC when compared to 25 and 35 g dosages. C. perfringens decreased linearly (P = 0.03) as LIPC dose increased. Butyrate decreased linearly (P = 0.01) as LIPC dose increased. CONCLUSION: Further studies should be conducted with a longer dosing period to examine the antimicrobial properties of curcumin without adversely affecting cecal characteristics. BioMed Central 2017-06-12 /pmc/articles/PMC5473976/ /pubmed/28638626 http://dx.doi.org/10.1186/s40781-017-0138-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Bland, S. D.
Venable, E. B.
McPherson, J. L.
Atkinson, R. L.
Effects of liposomal-curcumin on five opportunistic bacterial strains found in the equine hindgut - preliminary study
title Effects of liposomal-curcumin on five opportunistic bacterial strains found in the equine hindgut - preliminary study
title_full Effects of liposomal-curcumin on five opportunistic bacterial strains found in the equine hindgut - preliminary study
title_fullStr Effects of liposomal-curcumin on five opportunistic bacterial strains found in the equine hindgut - preliminary study
title_full_unstemmed Effects of liposomal-curcumin on five opportunistic bacterial strains found in the equine hindgut - preliminary study
title_short Effects of liposomal-curcumin on five opportunistic bacterial strains found in the equine hindgut - preliminary study
title_sort effects of liposomal-curcumin on five opportunistic bacterial strains found in the equine hindgut - preliminary study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473976/
https://www.ncbi.nlm.nih.gov/pubmed/28638626
http://dx.doi.org/10.1186/s40781-017-0138-4
work_keys_str_mv AT blandsd effectsofliposomalcurcuminonfiveopportunisticbacterialstrainsfoundintheequinehindgutpreliminarystudy
AT venableeb effectsofliposomalcurcuminonfiveopportunisticbacterialstrainsfoundintheequinehindgutpreliminarystudy
AT mcphersonjl effectsofliposomalcurcuminonfiveopportunisticbacterialstrainsfoundintheequinehindgutpreliminarystudy
AT atkinsonrl effectsofliposomalcurcuminonfiveopportunisticbacterialstrainsfoundintheequinehindgutpreliminarystudy